Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you today? Once again, a shiny sun is hovering over the freezing cold Pharmalot corporate campus, which we hope will soon warm up enough so we may effectively tackle our to-do list. To help us along - you guessed it - we are brewing another cup of steaming hot stimulation. Our flavor is Southern Pecan, if you care. In any event, time to get cracking. So here are some tidbits. Hope your day goes well and be in touch... Novartis CEO Envisions Tiered Pricing Plans For Africa (This Is Africa) FDA Approves First Generic Of Cymbalta Antidepresssant (Associated Press) Roche Signs Deal Worth Up To $600M For Prothena Parkinson's Drug (Reuters) Orexigen Resubmits Contrave Diet Drug To The FDA (Associated Press) FDA Panel Partially Backs Bristol-Myers Drug For Rare Fat Disorder (Reuters) Indian Court Ruling On Batch Pricing Upsets Drugmakers (Economic Times) China Bans Daewoong Antibiotics After Spot Checks Are Refused (China Times) Genzyme Gaucher Pill Gets FDA Priority Review (Pharma Times) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs